Pinnacle Associates LTD Atara Biotherapeutics, Inc. Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$0.44 - $1.22 $462 - $1,281	-1,050 Reduced 7.61%	12,740 $8,000
Q4 2023 Jan 19, 2024	SELL	$0.23 - $1.74 $85,462 - $646,538	-371,574 Reduced 96.42%	13,790 $7,000
Q3 2023 Oct 23, 2023	SELL	$1.41 - $2.31 $14,424 - $23,631	-10,230 Reduced 2.59%	385,364 $570,000
Q2 2023 Jul 26, 2023	SELL	$1.5 - $3.04 $5,583 - $11,314	-3,722 Reduced 0.93%	395,594 $636,000
Q1 2023 May 04, 2023	BUY	$2.8 - $5.46 $17,130 - $33,404	6,118 Added 1.56%	399,316 $1.16 Million
Q4 2022 Jan 31, 2023	SELL	$2.85 - $5.18 $73,173 - $132,996	-25,675 Reduced 6.13%	393,198 $1.29 Million
Q4 2022 Jan 25, 2023	BUY	$2.85 - $5.18 $58,308 - $105,977	20,459 Added 5.14%	418,873 $0
Q3 2022 Oct 31, 2022	SELL	$2.85 - $8.73 $86,335 - $264,457	-30,293 Reduced 7.07%	398,414 $1.51 Million
Q2 2022 Aug 02, 2022	SELL	$4.69 - $9.84 $4,966 - $10,420	-1,059 Reduced 0.25%	428,707 $3.34 Million
Q1 2022 May 05, 2022	SELL	$8.44 - $16.89 $168,276 - $336,752	-19,938 Reduced 4.43%	429,766 $3.99 Million
Q4 2021 Feb 02, 2022	SELL	$14.7 - $19.89 $31,208 - $42,226	-2,123 Reduced 0.47%	449,704 $7.09 Million
Q3 2021 Oct 19, 2021	SELL	$11.99 - $17.9 $181,288 - $270,648	-15,120 Reduced 3.24%	451,827 $8.09 Million
Q2 2021 Aug 02, 2021	BUY	$12.89 - $16.58 $88,335 - $113,622	6,853 Added 1.49%	466,947 $7.26 Million
Q1 2021 May 12, 2021	SELL	$14.0 - $20.72 $629,370 - $931,467	-44,955 Reduced 8.9%	460,094 $6.61 Million
Q4 2020 Jan 26, 2021	SELL	$12.67 - $26.23 $450,139 - $931,899	-35,528 Reduced 6.57%	505,049 $9.91 Million
Q3 2020 Oct 23, 2020	SELL	$11.92 - $15.87 $135,327 - $180,172	-11,353 Reduced 2.06%	540,577 $7.01 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $948,478 - $1.88 Million	125,960 Added 29.57%	551,930 $8.04 Million
Q1 2020 May 13, 2020	BUY	$5.69 - $17.78 $580,095 - $1.81 Million	101,950 Added 31.46%	425,970 $3.63 Million
Q4 2019 Feb 03, 2020	BUY	$10.89 - $16.79 $3.53 Million - $5.44 Million	324,020 New	324,020 $5.34 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $776M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account